Access Biotechnology — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

Mariana Oncologymarianaoncology.com in 𝕏Sep 2023 · $175M

Mariana Oncology, a Novartis company, develops precision radioligand therapies that deliver radioisotopes to diseased cells while limiting effects on healthy tissue.

BiotechHealthtechMedical Devices

Co-investorsAtlas Venture Nextech Invest Forbion RA Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.